Association of time‐varying clearance of nivolumab with disease dynamics and its implications on exposure response analysis
C Liu; J Yu; H Li; J Liu; Y Xu; P Song; Q Liu; H Zhao; J Xu; VE Maher; BP Booth; G Kim; A Rahman; Y Wang
Author Information: Food and Drug Administration
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.